Folic Acid Antioxidant Composition for Diabetic Neuropathy Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetic neuropathy are inadequate in effectively managing pain and preventing progression, with existing medications often causing side effects and having limited understanding of the disease's mechanistic aspects, leading to complications such as numbness, ulceration, and amputations.
Innovation Solution
A composition comprising a folic compound combined with specific antioxidants, including those with stabilizing heteroatoms and extended conjugated segments, which have pro-oxidant effects, is administered to reduce diabetic neuropathic pain by at least 50% within 3 to 5 days, as measured by the Neuropathic Pain Scale.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for diabetic neuropathy are administered, then pain management is attempted, but side effects occur and pain reduction is insufficient
Solution Approach 1:
The patent combines folic acid with multiple antioxidants (alpha-lipoic acid, vitamin C, vitamin E, and other polyphenolic compounds) to create a composite therapeutic formulation. This composite approach addresses the limitations of single-agent treatments by providing synergistic pain relief while reducing the side effects associated with conventional monotherapies.
Solution Approach 2:
The invention changes the chemical composition parameters of the treatment by introducing specific antioxidants with defined molecular structures and functional groups. These parameter changes in the therapeutic agent composition lead to improved efficacy and reduced harmful side effects compared to conventional treatments.
2Use of energy by moving object
If blood vessel dilating agents are administered to address microvascular injuries, then oxygen supply to nerves is improved, but the underlying oxidative stress and glycosylation damage are not addressed
Solution Approach 1:
The folic acid-antioxidant composition serves multiple functions simultaneously: it improves microvascular oxygen supply, scavenges reactive oxygen species, prevents protein glycosylation, and reduces neuropathic pain. This multi-functional approach addresses all major pathogenic mechanisms of diabetic neuropathy in a single therapeutic intervention.
Solution Approach 2:
The antioxidants in the composition act as intermediaries that mediate between the harmful oxidative environment and the vulnerable nerve tissues. These antioxidant compounds neutralize free radicals and prevent oxidative damage to neural structures, thereby protecting nerves from microvascular injury consequences.
3Reliability
If existing medications are used to manage diabetic neuropathy symptoms, then some pain relief is achieved, but the progression of neuropathy is not effectively prevented
Solution Approach 1:
The antioxidant formulation acts preliminarily to prevent oxidative damage before it can progress to permanent nerve injury. By scavenging free radicals and preventing lipid peroxidation early in the pathogenic process, the treatment prevents disease progression while also managing symptoms, rather than merely responding to established damage.
Data Source
AI summary
The invention provides compositions and methods to treat diabetic neuropathies. In particular the invention has discovered that, in combination with a folic compound, particular combinations of two types of additional antioxidants have complementary effects for use against diabetic neuropathies. These include antioxidants that comprise stabilizing heteroatoms and antioxidants with an extended conjugated segment, where at least one of the antioxidants that comprises a stabilizing heteroatom also has pro-oxidant effects.